| ACE2 | Angiotensin-converting enzyme 2 |
| ANS | Autonomic nervous system |
| ARDS | Acute respiratory distress syndrome |
| BBB | Blood–brain barrier |
| BDI | Beck Depression Inventory |
| C-19 | COVID-19 |
| CBC | Complete blood count |
| CBT | Cognitive behavioral therapy |
| CBT-I | Cognitive behavioral therapy for insomnia |
| CFS | Chronic fatigue syndrome |
| CFQ | Cognitive Failures Questionnaire |
| CIRCI | Critical illness-related corticosteroid insufficiency |
| CNS | Central nervous system |
| CoQ10 | Coenzyme Q10 |
| DHA | Docosahexaenoic acid |
| EAS | Extended autonomic system |
| EEG | Electroencephalogram |
| EMDR | Eye movement desensitization and reprocessing |
| EPA | Eicosapentaenoic acid |
| FIASMA | Inhibition of acid sphingomyelinase |
| GAD | Generalized anxiety disorder |
| GAD-7 | Generalized Anxiety Disorder-7 |
| HADS | Hospital Anxiety and Depression Scale |
| HPA | Hypothalamic–pituitary–adrenal |
| HRQoL | Health-related quality of life |
| QoL | quality of life |
| ICU | Intensive care unit |
| IL | Interleukins |
| L-C19 | Long COVID-19 |
| MBCT | Mindfulness-based cognitive therapy |
| MBSR | Mindfulness-based stress reduction |
| MCI | Mild cognitive impairment |
| MDD | Major depressive disorder |
| MMSE | Mini-Mental State Examination |
| MoCA | Montreal Cognitive Assessment |
| MRI | Magnetic resonance imaging |
| NAC | N-acetylcysteine |
| OCD | Obsessive–compulsive disorder |
| PASC | Post-acute sequelae of SARS-CoV-2 infection |
| PCL-5 | PTSD Checklist for DSM-5 |
| PEM | Post-exertional malaise |
| PHQ-9 | Patient Health Questionnaire |
| POTS | Postural orthostatic tachycardia syndrome |
| PTSD | Post-traumatic stress disorder |
| PSQI | Pittsburgh Sleep Quality Index |
| SSRI | Selective serotonin reuptake inhibitor |
| TSH | Thyroid-Stimulating Hormone |
| T4 | Thyroxine |